蛛网膜下腔出血后迟发性脑缺血的诊断与治疗存在较大实践差异
该研究通过基于网络的调查,向荷兰全部9家收治蛛网膜下腔出血(SAH)患者的医院的314名重症监护医师、神经内科医师和神经外科医师发放问卷,评估迟发性脑缺血(DCI)在定义、诊断和治疗方面的差异。应答率为34%(106/314),9家医院均有代表参与;其中79份应答用于分析。结果显示,在47名负责协调SAH治疗的医师中,21人(44%)在考虑DCI时要求存在血管痉挛征象,24人(51%)不使用诊断性检查结果来确立DCI阳性诊断;在73名应答者中,33人(45%)在患者21天内出院时未开具继续使用尼莫地平的处方;除一家医院外,其余医院均曾通过诱导高血压治疗DCI。作者认为,在缺乏循证治疗的情况下,有必要对管理进行标准化以优化DCI诊疗。
要点
- 在47名协调SAH治疗的医师中,21人(44%)在考虑DCI时要求存在血管痉挛征象。
- 在47名协调SAH治疗的医师中,24人(51%)不使用诊断性检查结果来确立DCI阳性诊断。
- 在73名应答者中,33人(45%)在患者21天内出院时未开具继续使用尼莫地平的处方。
核心结论
- 作者发现荷兰在DCI的定义、诊断和治疗方面存在较大差异;在缺乏循证治疗的情况下,有必要对管理进行标准化以优化DCI诊疗。
研究设计与样本
- 研究为基于网络的调查,问卷发放给荷兰全部9家收治SAH患者的医院的314名重症监护医师、神经内科医师和神经外科医师。
- 应答者被分为负责协调SAH治疗的医师与不负责协调的医师;关于定义和诊断的问题仅评估协调医师的应答,关于治疗的问题评估所有应答。
主要发现
- 应答率为34%(106/314),9家医院均有代表参与;106份应答中27份未提供定义、诊断或治疗问题的答案,79份应答用于分析。
- 在47名协调医师中,21人(44%)在考虑DCI时要求存在血管痉挛征象。
- 在47名协调医师中,24人(51%)不使用诊断性检查结果来确立DCI阳性诊断。
- 在73名应答者中,33人(45%)在患者21天内出院时未开具继续使用尼莫地平的处方。
- 除一家医院外,其余医院均曾通过诱导高血压治疗DCI。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Delayed cerebral ischemia (DCI) contributes to poor outcomes after subarachnoid hemorrhage (SAH). The pathophysiology of DCI is not fully understood, which has hindered the adoption of a uniform definition. Furthermore, a reliable diagnostic test and an effective evidence-based treatment are lacking. This could lead to variations in care. METHODS: A web-based survey on the variations in the definition, diagnosis, and treatment of DCI was designed and sent to 314 intensivists, neurologists, and neurosurgeons of all 9 hospitals in the Netherlands who care for patients with SAH. The responders were categorized into physicians responsible for the coordination of SAH care and those who were not. For questions on the definition and diagnosis, only the responses from the coordinating physicians were evaluated. For the treatment questions, all the responses were evaluated. RESULTS: The response rate was 34% (106 of 314). All 9 hospitals were represented. Of the responses, 27 did not provide answers for the definition, diagnosis, or treatment questions; 79 responses were used for analysis. Signs of vasospasm were required by 21 of the 47 coordinating physicians (44%) when considering DCI. Of the 47 coordinating physicians, 24 (51%) did not use a diagnostic test results for a positive diagnosis of DCI. When patients were discharged within 21 days, 33 of the 73 responders (45%) did not provide a prescription for nimodipine continuation. Finally, all but one hospital had treated DCI with hypertension induction. CONCLUSIONS: We found large variations in the definition, diagnosis, and treatment of DCI in the Netherlands. In the absence of evidence-based treatment, standardization of management seems warranted in an effort to optimize DCI care.
引用
- Tjerkstra MA, Verbaan D, Coert BA, et al. Large practice variations in diagnosis and treatment of delayed cerebral ischemia after subarachnoid hemorrhage. World Neurosurg. 2022. PMID: 35033694. doi:10.1016/j.wneu.2022.01.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。